Furthermore, recent studies suggest that the deposition of amyloid beta (Aβ) peptides, proteolytic fragments of APP, could be the overlapping molecular mechanism between Alzheimer’s disease and CAD. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.